Sales of Nubeqa (darolutamide), a drug developed jointly by
For the first commercial sale in the EU, Orion will receive a milestone payment of
Contact:
Tel: +358 10 426 2721
Web: www.orion.fi
Orion is a Finnish pharmaceutical company a builder of well-being that operates worldwide. Orion develops, manufactures and markets human and veterinary medicines as well as active pharmaceutical ingredients. The company constantly invests in research and development of new drugs and treatments. The core therapeutic areas of Orion's pharmaceutical research are central nervous system diseases, cancer diseases, rare diseases of the Finnish genetic heritage and respiratory diseases for the treatment of which Orion develops inhaled Easyhaler lung drugs. Orion's net sales in 2019 were
(C) 2020 Electronic News Publishing, source